HMGCR and cancer: The authors reported little evidence for an effect of HMGCR inhibition on overall cancer risk (HR equivalent to 0.07 mmol/L lowering of LDL cholesterol 0.99, 95% CI 0.95–1.02), though statistical power was modest for this analysis (n = 6528 cases).